Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials

Petersen, Lone K; Restrepo, Jaime; Moreira Junior, Edson Duarte; Iversen, Ole-Erik; Pitisuttithum, Punnee; Van Damme, Pierre; Joura, Elmar A; Olsson, Sven-Erik; Ferris, Daron; Block, Stan; Giuliano, Anna R; Bosch, Xavier; Pils, Sophie; Cuzick, Jack; Garland, Suzanne M; Huh, Warner; Kjaer, Susanne K; Bautista, Oliver M; Hyatt, Donna; Maansson, Roger; Moeller, Erin; Qi, Hong; Roberts, Christine; Luxembourg, Alain

Petersen, Lone K; Restrepo, Jaime; Moreira Junior, Edson Duarte; Iversen, Ole-Erik; Pitisuttithum, Punnee; Van Damme, Pierre; Joura, Elmar A; Olsson, Sven-Erik; Ferris, Daron; Block, Stan; Giuliano, Anna R; Bosch, Xavier; Pils, Sophie; Cuzick, Jack; Garland, Suzanne M; Huh, Warner; Kjaer, Susanne K; Bautista, Oliver M; Hyatt, Donna; Maansson, Roger; Moeller, Erin; Qi, Hong; Roberts, Christine; Luxembourg, Alain.

Afiliação

Petersen, Lone K; Associação Obras Sociais Irmã Dulce. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil.

Article em En | ARCA | ID: arc-25793

Palavras-chave

Vírus do papiloma humano; 9v Vacina contra o HPV; Imunogenicidade; Ensaio clínico; Human papillomavirus; 9v HPV vaccine; Immunogenicity; Clinical trial

Texto completo

Imprimir

XML

Buscar no Google